Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Intercell AG Announces Q1 2011 Results and Updates on R & D Progress

May 10, 2011 By Bio-Medicine.Org

VIENNA, May 10, 2011 /PRNewswire/ — Today, the biotech-vaccine
company Intercell AG (VSE: ICLL) announced its financial results
for Q1 and presented an update on the Company’s development
programs.

Financial Results

Year-on-year revenue growth of 19.7% driven by strong
IXIARO®/JESPECT® sales revenues Restructuring process
progressing successfully – operating loss reduced by 33.1%
Higher sales and reduced spending lead to reduced net loss of EUR
11.3m Cash position of EUR 87.7m at quarter-end Unchanged net loss
expectation of EUR 3

40m for full year 2011

Key Financial Figures EUR in thousands

3 months ended

March 31,Year ended Dec. 31,201120102010Revenues

5,6924,75634,215Net loss

(11,257)(14,702)(255,182)Net operating cash flow

(23,453)(15,468)(65,120)Cash and marketable securities, end
of period

87,697158,21686,182IXIARO®/JESPECT® Revenues from
IXIARO®/JESPECT® product sales increased from EUR 0,4m in
Q1 2010 to EUR 3.3m in Q1 2011. This excellent result in the
usually weakest quarter of the year – due to travel seasonality –
reflects the positive trend of increasing sales of
IXIARO®/JESPECT® a already seen in 2010 in key travel
markets and to U.S. military.

Intercell expects a growth of sales to the U.S. military in
2011 due to higher vaccination rates and the finally expired stock
of no longer manufactured JE-Vax®.

Intercell continues to expand the global availability of
IXIARO® by increasing the number of regulatory approvals and
subsequent launches in various global markets. Furthermore it is
planning to launch the product with its partner Novartis in
additional European countries as well as Hong Kong and Singapore as
the first Asian territories during 2011.

The U.S. authorities recently confirmed to Intercell that the
first postmarketing safety

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech